• metajournal
  • Join

    metajournal

    21 day free trial
    Articles. Pearls. Topics. Reviews. Journal Clubs.
    Stay informed.
  • Sign in
  • About
  • Pricing
  • Help
  • Blog
  • Articles
  • Knowledge
  • Topics
  • Notes

Urologic oncology

The most recent articles from: Urol. Oncol. September 2012
  • Latest
  • Best
  • Search…

editorials · reviews · multicenter studies · meta-analyses · randomized controlled trials · retractions

  • Urologic oncology · Sep 2012

    Comment

    Commentary on "surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: an analysis of 2 randomized trials." A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA: Lancet Oncol 2012;13:189-95 [Epub;2011, November 21].

    no abstract available

    keep going… or just mark as read…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.

Loading...

Welcome to metajournal!

Sign up for your free metajournal

Receive a weekly email with the highest quality and most significant abstracts from critical care specialties.

Anesthesiology, Critical Care Medicine, Emergency Medicine, Medicine, and Pain medicine.

Includes a free 21 day trial of metajournal premium

  • Personalized abstracts
  • Institutional full-text access
  • Article collections
  • Save favorite articles
  • CME audit reports
  • Journal clubs and more...

We guarantee your privacy. Your email address will not be shared. Unsubscribe anytime.

No thanks, I'm up to date...
metajournal.com @themetajournal by @djoll · Privacy Policy · Terms of Service · v2.0.1
  • About
  • ·
  • Contact
  • ·
  • Pricing
  • ·
  • Help
  • ·
  • FAQ
  • ·
  • Blog
Copyright © 2025 Metajournal Pty Ltd. ACN 600 504 363. ABN 47 600 504 363. Hobart TAS, AUSTRALIA.
Publication data is provided by the National Library of Medicine and PubMed. Please refer to the NCBI's Disclaimer and Copyright notice.